Page last updated: 2024-08-26

fulvestrant and Uterine Neoplasms

fulvestrant has been researched along with Uterine Neoplasms in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	7 (70.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, X; Jun, L; Li, W; Ma, J; Wu, R; Ye, X	1
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH	1
Audebert, A; Donnez, J; Hervais Vivancos, B; Jadoul, P; Kudela, M	1
Amant, F; Joubert, A; Lindeque, BG; Lottering, ML; Thaver, V; Vergote, I	1
Beckmann, K; Beckmann, MW; Lux, MP; Thiel, F; Wenkel, EM	1
Asselin, E; Bélanger, G; Boucher, V; Déry, MC; Leblanc, K; Parent, S; Sexton, E	1
Fuchs-Young, R; Hale, L; Howe, S; Miles, R; Walker, C	1
Bergerson, JS; Hodges, LC; Hunter, DS; Walker, CL	1
Boettger-Tong, H; Chiappetta, C; Huang, JC; Hyder, SM; Mäkelä, S; Nawaz, Z; Stancel, GM	1
Barbarisi, A; Cannas, M; Di Lieto, A; Margarucci, S; Melone, MA; Peluso, G; Petillo, O	1

Reviews

2 review(s) available for fulvestrant and Uterine Neoplasms

Article	Year
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review. Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1 Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins	2016
Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environmental health perspectives, 2000, Volume: 108 Suppl 5 Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Hormone Antagonists; Humans; Leiomyoma; Lymphokines; Mifepristone; Progestins; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Transcription, Genetic; Uterine Neoplasms; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000

Article

Year

An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.

Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1

Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins

2016

Regulation of vascular endothelial growth factor expression by estrogens and progestins.

Environmental health perspectives, 2000, Volume: 108 Suppl 5

Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Hormone Antagonists; Humans; Leiomyoma; Lymphokines; Mifepristone; Progestins; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Transcription, Genetic; Uterine Neoplasms; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000

Trials

1 trial(s) available for fulvestrant and Uterine Neoplasms

Article	Year
A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy. Fertility and sterility, 2003, Volume: 79, Issue:6 Topics: Adult; Biopsy; Bone Resorption; Endometrium; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Goserelin; Humans; Hysterectomy; Leiomyoma; Middle Aged; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	2003

Article

Year

A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.

Fertility and sterility, 2003, Volume: 79, Issue:6

Topics: Adult; Biopsy; Bone Resorption; Endometrium; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Goserelin; Humans; Hysterectomy; Leiomyoma; Middle Aged; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms

2003

Other Studies

7 other study(ies) available for fulvestrant and Uterine Neoplasms

Article	Year
G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:11 Topics: Adult; Blotting, Western; Cell Proliferation; Cells, Cultured; Down-Regulation; Estradiol; Estrogens; Female; Fulvestrant; Humans; Immunohistochemistry; Leiomyoma; Middle Aged; Mitogen-Activated Protein Kinases; Mitosis; Myocytes, Smooth Muscle; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Up-Regulation; Uterine Myomectomy; Uterine Neoplasms	2015
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. Gynecologic oncology, 2003, Volume: 91, Issue:2 Topics: Antineoplastic Agents, Hormonal; Carcinosarcoma; Cell Cycle; Cell Division; Cell Line, Tumor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Progesterone; Raloxifene Hydrochloride; Tamoxifen; Triptorelin Pamoate; Uterine Neoplasms	2003
Fulvestrant: a further treatment option for patients with metastatic uterine cancer? Onkologie, 2006, Volume: 29, Issue:12 Topics: Antineoplastic Agents, Hormonal; Estradiol; Female; Fulvestrant; Humans; Liver Neoplasms; Middle Aged; Receptors, Estrogen; Treatment Outcome; Urinary Bladder Neoplasms; Uterine Neoplasms	2006
Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. International journal of oncology, 2007, Volume: 30, Issue:2 Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Prohibitins; Protein Binding; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, G-Protein-Coupled; Tamoxifen; Uterine Neoplasms	2007
Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Molecular carcinogenesis, 1996, Volume: 17, Issue:3 Topics: Animals; Cell Division; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Leiomyoma; Phenotype; Piperidines; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms	1996
Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro. Toxicological sciences : an official journal of the Society of Toxicology, 2000, Volume: 54, Issue:2 Topics: Animals; Cell Division; Chlordecone; Endosulfan; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Genes, Reporter; Insecticides; Leiomyoma; Myometrium; Phenols; Rats; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Uterine Neoplasms	2000
17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. Journal of cellular physiology, 2001, Volume: 186, Issue:3 Topics: Cell Division; Cell Survival; Culture Media, Conditioned; Estradiol; Estrogen Receptor Modulators; Female; Fibroblast Growth Factor 2; Fulvestrant; Humans; Kinetics; Leiomyoma; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphotyrosine; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-raf; Receptors, Estradiol; Receptors, Platelet-Derived Growth Factor; Tumor Cells, Cultured; Uterine Neoplasms	2001